IVERIC bio Inc. (ISEE)
NASDAQ: ISEE
· Real-Time Price · USD
39.95
0.15 (0.38%)
At close: Jul 10, 2023, 8:00 PM
0.38% (1D)
| Bid | n/a |
| Market Cap | 5.51B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -212.14M |
| EPS (ttm) | -1.78 |
| PE Ratio (ttm) | -22.4438202247191 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 10,801,886 |
| Avg. Volume (20D) | 4,945,949 |
| Open | 39.86 |
| Previous Close | 39.80 |
| Day's Range | 39.85 - 39.98 |
| 52-Week Range | 9.39 - 39.99 |
| Beta | 1.10 |
About ISEE
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degenera...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 25, 2013
Employees 163
Stock Exchange NASDAQ
Ticker Symbol ISEE
Website https://ivericbio.com